Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer

Clinical trial NCT01924260 · COMPLETED

Trial details

NCT number: NCT01924260
Sponsor: Edward Kim
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acinar Cell Adenocarcinoma of the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage III Pancreatic Cancer Stage IV Pancreatic Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2013-08-09
Primary completion: 2017-02-08
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.